Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8762
|
pubmed:dateCreated |
1991-8-21
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
338
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
321
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1677144-Adult,
pubmed-meshheading:1677144-Antibodies, Monoclonal,
pubmed-meshheading:1677144-Antigens, CD4,
pubmed-meshheading:1677144-Drug Administration Schedule,
pubmed-meshheading:1677144-Humans,
pubmed-meshheading:1677144-Male,
pubmed-meshheading:1677144-Middle Aged,
pubmed-meshheading:1677144-Psoriasis
|
pubmed:year |
1991
|
pubmed:articleTitle |
CD4 antibody treatment of severe psoriasis.
|
pubmed:publicationType |
Letter,
Clinical Trial,
Comment,
Case Reports
|